DE60039247D1 - Spiro(2h-1-benzopyran-2,4'-piperidin)derivate als glycintransporthemmer - Google Patents

Spiro(2h-1-benzopyran-2,4'-piperidin)derivate als glycintransporthemmer

Info

Publication number
DE60039247D1
DE60039247D1 DE60039247T DE60039247T DE60039247D1 DE 60039247 D1 DE60039247 D1 DE 60039247D1 DE 60039247 T DE60039247 T DE 60039247T DE 60039247 T DE60039247 T DE 60039247T DE 60039247 D1 DE60039247 D1 DE 60039247D1
Authority
DE
Germany
Prior art keywords
glycintransporthermmer
benzopyrano
spiro
piperidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60039247T
Other languages
English (en)
Inventor
Samuel George Gibson
David John Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of DE60039247D1 publication Critical patent/DE60039247D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60039247T 1999-11-17 2000-11-13 Spiro(2h-1-benzopyran-2,4'-piperidin)derivate als glycintransporthemmer Expired - Lifetime DE60039247D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99309137 1999-11-17
PCT/EP2000/011351 WO2001036423A1 (en) 1999-11-17 2000-11-13 Spiro(2h-1-benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors

Publications (1)

Publication Number Publication Date
DE60039247D1 true DE60039247D1 (de) 2008-07-31

Family

ID=8241739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60039247T Expired - Lifetime DE60039247D1 (de) 1999-11-17 2000-11-13 Spiro(2h-1-benzopyran-2,4'-piperidin)derivate als glycintransporthemmer

Country Status (29)

Country Link
US (2) US6645973B1 (de)
EP (1) EP1232160B1 (de)
JP (1) JP4825386B2 (de)
KR (1) KR100776226B1 (de)
CN (1) CN1199974C (de)
AR (1) AR026487A1 (de)
AT (1) ATE398622T1 (de)
AU (1) AU779518B2 (de)
BR (1) BR0015586A (de)
CA (1) CA2389491C (de)
CO (1) CO5261618A1 (de)
CY (1) CY1108339T1 (de)
CZ (1) CZ293920B6 (de)
DE (1) DE60039247D1 (de)
DK (1) DK1232160T3 (de)
ES (1) ES2307536T3 (de)
HK (1) HK1047282B (de)
HU (1) HUP0204162A3 (de)
IL (2) IL149286A0 (de)
NO (1) NO327743B1 (de)
NZ (1) NZ518671A (de)
PE (1) PE20010750A1 (de)
PL (1) PL206071B1 (de)
PT (1) PT1232160E (de)
RU (1) RU2250211C2 (de)
SK (1) SK287040B6 (de)
TW (1) TWI243173B (de)
WO (1) WO2001036423A1 (de)
ZA (1) ZA200203320B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) * 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
FR2842804B1 (fr) * 2002-07-29 2004-09-03 Sanofi Synthelabo Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
CA2541014A1 (en) * 2003-10-01 2005-04-14 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
ES2295963T3 (es) 2004-01-08 2008-04-16 F. Hoffmann-La Roche Ag Derivados diaza-espiropiperidina como inhibidores del transportador 1 de glicina y transportador 2 de glicina.
EP1720873B1 (de) * 2004-01-08 2011-02-23 F. Hoffmann-La Roche AG Diazaspiropiperidinderivate
WO2005092442A2 (en) * 2004-03-22 2005-10-06 Apkarian Vania A Method and compositions for treatment of chronic neuropathic pain
US7598261B2 (en) * 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CN101184749B (zh) * 2005-03-31 2012-12-05 阿得罗公司 螺环杂环衍生物及其使用方法
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CA2648831A1 (en) * 2006-05-05 2007-11-15 Ulrich Reiser Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
WO2008033299A2 (en) * 2006-09-12 2008-03-20 Adolor Corporation Use of n-containing spirocompounds for the enhancement of cognitive function
TWI366565B (en) 2007-06-06 2012-06-21 Otsuka Pharma Co Ltd Quinolone compound and pharmaceutical composition
KR100888468B1 (ko) * 2007-08-31 2009-03-11 한국화학연구원 항암활성을 갖는1'-알킬피페리딘-4'-스피로-2-6-(아미도)-2h-벤조피란유도체
US20100317679A1 (en) * 2007-09-21 2010-12-16 Ligand Pharmaceuticals, Inc. Substituted aryl-fused spirocyclic amines
EP2380595A1 (de) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Zusammensetzungen und Verfahren zur selektiven Abgabe von Oligonukleotidmolekülen an spezifische Neuronentypen
TWI543984B (zh) * 2010-07-09 2016-08-01 艾伯維公司 作為s1p調節劑的螺-哌啶衍生物
US20170143681A1 (en) 2015-11-02 2017-05-25 Apkarian Technologies Llc Methods and compositions for treating pain
CN116621187B (zh) * 2023-07-24 2023-09-22 江苏泓顺硅基半导体科技有限公司 一种用于高温氯化提纯石英砂的设备

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243065A (en) 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
FR2689509B1 (fr) * 1992-04-01 1994-06-03 Adir Nouveaux derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
DK78692D0 (da) 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
IL107881A0 (en) * 1992-12-05 1994-04-12 Fisons Corp Furanone derivatives and pharmaceutical compositions containing them
WO1994018204A1 (en) * 1993-02-12 1994-08-18 Merck & Co., Inc. Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics
US5484923A (en) * 1993-06-10 1996-01-16 Merck & Co., Inc. Process of making spirocycles and analogs thereof
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
GB9421003D0 (en) * 1994-10-18 1994-12-07 Smithkline Beecham Plc Novel compounds
US5654316A (en) 1995-06-06 1997-08-05 Schering Corporation Piperidine derivatives as neurokinin antagonists
ATE320804T1 (de) 1995-12-07 2006-04-15 Daniel C Javitt Behandlung negativer und kognitiver symptome der schizophrenie mit antagonisten der glycinaufnahme
HUP9600928A3 (en) * 1996-04-10 1999-03-29 Richter Gedeon Vegyeszet Use of spiro[2h-1-benzopyran-2,4'-piperidin]-4(3h)-one derivatives for the preparation of pharmaceutical compositions treating dementia, novel derivatives and process for their preparation
CA2255727A1 (en) 1996-05-31 1997-12-04 Trophix Pharmaceuticals, Inc. Pharmaceutical for treating of neurological and neuropsychiatric disorders
EP1014966B1 (de) 1996-05-31 2006-08-02 Allelix Neuroscience Inc. Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
US5919653A (en) 1996-08-20 1999-07-06 Allelix Neuroscience Inc. Nucleic acids encoding a human glycine transporter
AU2030999A (en) 1998-01-09 1999-07-26 Allelix Neuroscience, Inc. Glycine transport inhibitors
TW555757B (en) 1998-07-31 2003-10-01 Akzo Nobel Nv Aminomethylcarboxylic acid derivatives
TWI243173B (en) * 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
JP4033676B2 (ja) * 2000-04-27 2008-01-16 バジリア ファルマスーチカ アーゲー 抗菌剤としてのクロメニルメチルピリミジンジアミン類

Also Published As

Publication number Publication date
AU779518B2 (en) 2005-01-27
HK1047282B (zh) 2008-08-29
JP2003527340A (ja) 2003-09-16
PL355975A1 (en) 2004-05-31
US20040029904A1 (en) 2004-02-12
HUP0204162A3 (en) 2006-01-30
NO20022320D0 (no) 2002-05-15
ZA200203320B (en) 2003-08-27
DK1232160T3 (da) 2008-10-06
IL149286A (en) 2008-08-07
US7507824B2 (en) 2009-03-24
US6645973B1 (en) 2003-11-11
CA2389491A1 (en) 2001-05-25
KR20020050287A (ko) 2002-06-26
WO2001036423A1 (en) 2001-05-25
PL206071B1 (pl) 2010-06-30
ES2307536T3 (es) 2008-12-01
RU2250211C2 (ru) 2005-04-20
ATE398622T1 (de) 2008-07-15
HK1047282A1 (en) 2003-02-14
EP1232160A1 (de) 2002-08-21
EP1232160B1 (de) 2008-06-18
NO20022320L (no) 2002-05-15
CN1390221A (zh) 2003-01-08
CO5261618A1 (es) 2003-03-31
JP4825386B2 (ja) 2011-11-30
CZ293920B6 (cs) 2004-08-18
SK8432002A3 (en) 2002-10-08
SK287040B6 (sk) 2009-10-07
CN1199974C (zh) 2005-05-04
IL149286A0 (en) 2002-11-10
BR0015586A (pt) 2002-07-09
NZ518671A (en) 2003-10-31
AR026487A1 (es) 2003-02-12
HUP0204162A2 (hu) 2003-04-28
AU1521901A (en) 2001-05-30
TWI243173B (en) 2005-11-11
CZ20021724A3 (cs) 2002-08-14
CY1108339T1 (el) 2014-02-12
KR100776226B1 (ko) 2007-11-16
NO327743B1 (no) 2009-09-14
PT1232160E (pt) 2008-09-30
PE20010750A1 (es) 2001-07-19
CA2389491C (en) 2010-11-02

Similar Documents

Publication Publication Date Title
DE60039247D1 (de) Spiro(2h-1-benzopyran-2,4'-piperidin)derivate als glycintransporthemmer
DE69800896D1 (de) 8-substituierte-1,3,8-Triazaspiro[4,5]decan-4-onderivate
ATE216999T1 (de) Pyrimidin-4-on derivate als pestizidesmittel
AU6751301A (en) 1,3,8-triaza-spiro'4,5]decan-4-one derivatives as neurokinin receptor antagonists
PL364469A1 (en) Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
DE69605430D1 (de) Chinolin-2-on derivate als serotonin antagonisten
DE60005838D1 (de) 8-PHENYL-6,9-DIHYDRO-[1,2,4]TRIAZOLO[3,4-i]PURIN-5-ON DERIVATE
DE69803653D1 (de) 1,3,8-Triazaspiro[4,5]decan-4-on-derivate
AU7377200A (en) Combination therapy including camptothecin
DE69925036D1 (de) Spiro verbindungen mit antihistaminischer aktivität
DK0970957T3 (da) Diaza-spiro[3.5]nonan-derivativer
ID25776A (id) Hidrohalogenida-hidrohalogenida 1'-(-4-(1-(4-flourofenil)-1-h-indola-3-il)-1-butil)-spiro (isobenzofuran-1(3h),4-piperidin
AU3611093A (en) Substituted furo(3',4':6,7)indolizino(1,2-b)quinolinones
PT963987E (pt) Spiro(piperidina-4,1'-pirrolo(3,4-c)pirrolo)
DE69801556D1 (de) Spirocyclische Verbindungen
ZA993853B (en) Spiro[piperidine-4,1'-pyrolo(3,4-C)pyrrole].
NO975781D0 (no) Nye spiro £2H-1-benzopyran-2,4'-piperidin|-4(3H)-on-derivater, syreaddisjonssalter derav, og farmasöytiske preparater inneholdende disse
HUP9701558A3 (en) Spiro{furo[2,3-f]indol-3,4'-piperidine}derivative, process for the preparation thereof, use and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1232160

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE